Seth Seegobin
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Dermatology top 5%
- Hidradenitis Suppurativa and Treatments
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 9
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- J. Wanders (9 shared papers)Linda T. Vahdat (8 shared papers)Javier Cortés (9 shared papers)Fátima Cardoso (3 shared papers)Corina E. Dutcus (2 shared papers)Joyce O’Shaughnessy (2 shared papers)Katarína Petráková (3 shared papers)Joanne L. Blum (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Open Forum Infectious Diseases (3 papers)PLoS Genetics (2 papers)The FASEB Journal (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Seth Seegobin
19 papers receiving 1.3k citations
Seth Seegobin's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 649
- Dermatology 136
- Cancer Research 142
- Rheumatology 102
- Pulmonary and Respiratory Medicine 199
Countries citing papers authored by Seth Seegobin
This map shows the geographic impact of Seth Seegobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Seegobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Seegobin more than expected).
Fields of papers citing papers by Seth Seegobin
This network shows the impact of papers produced by Seth Seegobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Seegobin. The network helps show where Seth Seegobin may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth Seegobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 817 |
| 2 | 2021 | 117 | |
| 3 | 2017 | 100 | |
| 4 | 2014 | 73 | |
| 5 | 2013 | 55 | |
| 6 | 2014 | 35 | |
| 7 | 2010 | 29 | |
| 8 | 2021 | 25 | |
| 9 | 2015 | 22 | |
| 10 | 2016 | 21 | |
| 11 | 2007 | 11 | |
| 12 | 2010 | 5 | |
| 13 | 2011 | 5 | |
| 14 | 2013 | 4 | |
| 15 | 2010 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2010 | 2 | |
| 18 | 2011 | 2 | |
| 19 | 2014 | 1 | |
| 20 | 2022 | 0 |
About Seth Seegobin
Seth Seegobin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Rheumatology, Infectious Diseases and Immunology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Systemic Lupus Erythematosus Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (649 citations), Dermatology (136 citations), Cancer Research (142 citations), Rheumatology (102 citations) and Pulmonary and Respiratory Medicine (199 citations). Seth Seegobin has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include J. Wanders, Linda T. Vahdat, Javier Cortés, Fátima Cardoso, Corina E. Dutcus, Joyce O’Shaughnessy, Katarína Petráková, Joanne L. Blum, P. Chollet and Véronique Dièras. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Open Forum Infectious Diseases, PLoS Genetics and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.